Recently, resonance coupling between plasmonic nanocavity and two-dimensional semiconductors has attracted considerable attention. Most of the previous studies have focused on demonstrating this effect with light scattering or reflection spectroscopy, while the photoluminescence (PL) spectrum can help ascertain the underlying physics. Here, we report on the lightemitting characteristics of a monolayer WS 2 flake coupled with a plasmonic gold nanorod. We construct a heterostructure by integrating an individual gold nanorod on top of a small piece of monolayer WS 2 , where the WS 2 area is determined by the projected area of the nanorod. In such a heterostructure, the background PL from the uncoupled WS 2 can be suppressed, which allows us to characterize the resonance coupling effect using correlated single-particle dark-field (DF) scattering and PL spectroscopies. Distinct mode splitting and anticrossing dispersion are observed in the scattering spectra, which originate from the resonance coupling between the excitons in the WS 2 and plasmon resonance in the gold nanorod. In addition, a 1187-fold enhancement is obtained for the light emitted from the heterostructure relative to that of the pristine monolayer WS 2 . The emission spectra are broadened with mode-splitting features at room temperature, which can be further decomposed into two resonance modes using a coupled mode analysis. Moreover, two PL modes are polarized along the longitudinal axis of the gold nanorod. These findings show the potential of the designed individual gold nanorod−monolayer WS 2 heterostructure as a platform for studying the resonance coupling effect between plasmon resonance and two-dimensional excitons.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.